VANCOUVER, BC — Ten-year results from the Canadian Registry of Atrial Fibrillation (CARAF) of more than 700 patients with paroxysmal AF showed that only 36% of patients went on to have persistent AF ...

As effective as catheter ablation can be for patients with paroxysmal atrial fibrillation (AF), the procedure that aims for pulmonary vein isolation (PVI) has met much less success in those with ...

There is increased risk for new-onset, persistent AF in older male patients with obesity without history of cardiovascular disease, AF, or cancer. Among healthy adults without cardiovascular disease ...

Please provide your email address to receive an email when new articles are posted on . Persistent atrial fibrillation was an independent predictor of poor outcomes after catheter ablation. Ablation ...

Ablation therapy could be an effective treatment for patients with persistent atrial fibrillation (AF). In a randomized, controlled trial comparing catheter ablation with antiarrhythmic drug therapy, ...

In patients with persistent atrial fibrillation (AF), standard treatment with pulmonary vein isolation (PVI) ablation resulted in similar outcomes to more extensive ablation in other areas of the ...

Please provide your email address to receive an email when new articles are posted on . Thoracoscopic surgical ablation for long-standing persistent atrial fibrillation was not superior to catheter ...

VIENNA, Austria—For patients with persistent atrial fibrillation (AF), a hybrid approach that combines a minimally invasive surgical ablation with catheter-based radiofrequency ablation—performed ...

MINNEAPOLIS - Medtronic, Inc. today announced the first patient has been enrolled in the VICTORY AF clinical trial, a prospective, non-randomized, controlled study of patients with persistent or ...

A novel three-catheter radiofrequency ablation system has been reported to reduce procedure time, but maintain ablation success rates, in patients with persistent atrial fibrillation. The findings are ...

Biosense Webster Inc. reported U.S. FDA approval of its Thermocool Smarttouch SF ablation catheter for the treatment of patients with persistent atrial fibrillation (persistent AF). This follows ...